18F-fluorodeoxyglucose positron emission tomography in dementia with Lewy bodies
暂无分享,去创建一个
David T. Jones | C. Jack | J. Gunter | R. Petersen | J. Graff‐Radford | B. Boeve | T. Ferman | S. Przybelski | T. Lesnick | M. Senjem | D. Knopman | V. Lowe | K. Kantarci | W. Kremers | M. Murray | D. Dickson | R. Savica | Qin Chen
[1] Alan J. Thomas,et al. Neuropathological Changes in Dementia With Lewy Bodies and the Cingulate Island Sign , 2019, Journal of neuropathology and experimental neurology.
[2] J. Trojanowski,et al. Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders , 2018, Annals of neurology.
[3] J. Graff‐Radford,et al. The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies , 2018, Alzheimer's & Dementia.
[4] Alan J. Thomas,et al. Diagnosis and management of dementia with Lewy bodies , 2017, Neurology.
[5] Clifford R. Jack,et al. THE MAYO CLINIC ADULT LIFESPAN TEMPLATE: BETTER QUANTIFICATION ACROSS THE LIFESPAN , 2017, Alzheimer's & Dementia.
[6] H. Matsuda,et al. Validation of the cingulate island sign with optimized ratios for discriminating dementia with Lewy bodies from Alzheimer’s disease using brain perfusion SPECT , 2017, Annals of Nuclear Medicine.
[7] David T. Jones,et al. Duration and Pathologic Correlates of Lewy Body Disease , 2017, JAMA neurology.
[8] T. Montine,et al. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis , 2017, The Lancet Neurology.
[9] W. M. van der Flier,et al. Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies , 2016, Journal of Neurology, Neurosurgery & Psychiatry.
[10] David T. Jones,et al. Predicting Survival in Dementia With Lewy Bodies With Hippocampal Volumetry , 2016, Movement disorders : official journal of the Movement Disorder Society.
[11] M. Kameyama,et al. Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies , 2016, Annals of Nuclear Medicine.
[12] Matthew L Senjem,et al. Dementia with Lewy bodies , 2014, Neurology.
[13] D. Aarsland,et al. Time until nursing home admission in people with mild dementia: comparison of dementia with Lewy bodies and Alzheimer's dementia , 2014, International journal of geriatric psychiatry.
[14] C. Jack,et al. Multimodality imaging characteristics of dementia with Lewy bodies , 2012, Neurobiology of Aging.
[15] C. Jack,et al. Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies. , 2012, Brain : a journal of neurology.
[16] J. Schneider,et al. National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease , 2012, Alzheimer's & Dementia.
[17] Ronald C Petersen,et al. Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort. , 2011, Sleep medicine.
[18] Arno Klein,et al. A reproducible evaluation of ANTs similarity metric performance in brain image registration , 2011, NeuroImage.
[19] C. Rowe,et al. The 18F-FDG PET Cingulate Island Sign and Comparison to 123I-β-CIT SPECT for Diagnosis of Dementia with Lewy Bodies , 2009, Journal of Nuclear Medicine.
[20] R. Petersen,et al. Validation of the Neuropathologic Criteria of the Third Consortium for Dementia With Lewy Bodies for Prospectively Diagnosed Cases , 2008, Journal of neuropathology and experimental neurology.
[21] J. Morris,et al. Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease , 2006, Neurology.
[22] D W Dickson,et al. DLB fluctuations , 2004, Neurology.
[23] R. Mohs,et al. Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.
[24] N. Tzourio-Mazoyer,et al. Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.
[25] L. Thal,et al. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease , 1998, Neurology.
[26] C. Clark,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1994, Neurology.
[27] J. Morris. The Clinical Dementia Rating (CDR) , 1993, Neurology.
[28] D. Greenblatt,et al. The International Classification of Sleep Disorders , 1992 .
[29] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.
[30] J. Duchek,et al. Mild senile dementia of the alzheimer type: 2. Longitudinal assessment , 1988, Annals of neurology.
[31] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.